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Dyslipidemia awareness, treatment, control and influence factors among adults
in the Jilin province in China: a cross-sectional study
Abstract
Background In China, even though the prevalence of dyslipidemia among adults increased yearly and
dyslipidemia being an important risk factor for cardiovascular diseases among the Chinese population,
however, the awareness, treatment and control of dyslipidemia are at low levels, and only limited studies
on the influence factors associated with the awareness, treatment and control dyslipidemia in China have
been carried out. Methods The analysis was based on a representative sample of 7138 adult subjects
aged 18 ~ 79 years recruited from a cross-sectional study of chronic disease and risk factors among
adults in the Jilin province in 2012. Chi-square test was used to compare the rates of dyslipidemia
awareness, treatment and control between different characteristics of participants. Multiple logistic
regression analyses were performed separately for each group to explore the associations between
participants' characteristics and dyslipidemia awareness, treatment and control. Results Among
participants with dyslipidemia, 11.6% were aware of the diagnosis, 8.4% were receiving treatment, and
34.8% had dyslipidemia controlled. Increase in age and BMI ≥ 24 kg/m2 were by far the strongest risk
factors associated with better awareness and treatment of dyslipidemia. Retirees were more likely to be
aware of their dyslipidemia condition (OR = 1.255; 95% CI: 1.046, 1.506) and to be receiving treatment (OR
= 1.367; 95% CI: 1.114, 1.676) than manual workers. A family history of dyslipidemia increased the
likelihood of awareness (OR = 3.620; 95% CI: 2.816, 4.653) and treatment (OR = 3.298; 95% CI: 2.488,
4.371) of dyslipidemia. Alcohol drinking and physical activity were associated with a lower level of
awareness and treatment. Cigarette smokers (OR = 0.501; 95% CI: 0.349, 0.719) and those with BMI ≥ 24
kg/m2 (OR = 0.480; 95% CI: 0.326, 0.706) who received treatment were also associated with poor
dyslipidemia control. Conclusion Our study highlights low levels of awareness, poor treatment and control
of dyslipidemia among adults aged 18 ~ 79 in the Jilin province. Promotion of healthy lifestyles and
establishment of a comprehensive strategy of screening, treatment and control of dyslipidemia is needed
to reduce or prevent the risk of cardiovascular disease in the Jilin province.
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Abstract
Background: In China, even though the prevalence of dyslipidemia among adults increased yearly and dyslipidemia
being an important risk factor for cardiovascular diseases among the Chinese population, however, the awareness,
treatment and control of dyslipidemia are at low levels, and only limited studies on the influence factors associated
with the awareness, treatment and control dyslipidemia in China have been carried out.
Methods: The analysis was based on a representative sample of 7138 adult subjects aged 18 ~ 79 years recruited from
a cross-sectional study of chronic disease and risk factors among adults in the Jilin province in 2012. Chi-square test
was used to compare the rates of dyslipidemia awareness, treatment and control between different characteristics
of participants. Multiple logistic regression analyses were performed separately for each group to explore the associations
between participants’ characteristics and dyslipidemia awareness, treatment and control.
Results: Among participants with dyslipidemia, 11.6% were aware of the diagnosis, 8.4% were receiving treatment, and
34.8% had dyslipidemia controlled. Increase in age and BMI ≥ 24 kg/m2 were by far the strongest risk factors associated
with better awareness and treatment of dyslipidemia. Retirees were more likely to be aware of their dyslipidemia
condition (OR = 1.255; 95% CI: 1.046, 1.506) and to be receiving treatment (OR = 1.367; 95% CI: 1.114, 1.676) than manual
workers. A family history of dyslipidemia increased the likelihood of awareness (OR = 3.620; 95% CI: 2.816, 4.653) and
treatment (OR = 3.298; 95% CI: 2.488, 4.371) of dyslipidemia. Alcohol drinking and physical activity were associated with a
lower level of awareness and treatment.
Cigarette smokers (OR = 0.501; 95% CI: 0.349, 0.719) and those with BMI ≥ 24 kg/m2 (OR = 0.480; 95% CI: 0.326, 0.706) who
received treatment were also associated with poor dyslipidemia control.
Conclusion: Our study highlights low levels of awareness, poor treatment and control of dyslipidemia among adults
aged 18 ~ 79 in the Jilin province. Promotion of healthy lifestyles and establishment of a comprehensive strategy of
screening, treatment and control of dyslipidemia is needed to reduce or prevent the risk of cardiovascular disease in
the Jilin province.
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Introduction
In China, the prevalence of dyslipidemia among adults
increases yearly and dyslipidemia is now an important
risk factor for cardiovascular diseases in the Chinese
population [1,2]. The results from the Chinese National
and Health Survey in 2002 showed that the prevalence
of dyslipidemia in the Chinese population was 18.6% [3].
The study of Wang et al. [4] reported that the prevalence of dyslipidemia in the Beijing adult population was
56.1% in 2006. Luo et al. [5] reported that prevalence of
dyslipidemia was 52.72% among adults in northwestern
China in 2010. CVD is characterized by high morbidity
of stroke and low morbidity of coronary heart disease,
but morbidity and mortality of coronary heart diseases
have gradually increased in the last 20 years in China
[6]. The report of the third recalled sample survey on
the causes of death in China showed that in the last
15 years, the proportion of deaths from chronic diseases
among residents increased from 76.5% to 82.5% among
residents, and cardiovascular death was the first cause
[7]. It is apparent that China will continue to experience
significant increase in the prevalence of cardiovascularrelated morbidity and mortality, which has the potential
to create an enormous burden on the health care system
in the future [8].
Moreover, the asymptomatic characteristics of dyslipidemia contribute to the increased incidence of CVD
and sudden death, thus uncontrolled dyslipidemia is a
serious risk factor for cardiovascular events such as coronary heart disease, cerebral ischemic attack, cerebral
infarction and peripheral vascular disease [9,10]. Large
clinical trials have demonstrated that the treatment of
dyslipidemia is effective in both primary and secondary
prevention of CVD [11,12]. Treating dyslipidemia can
reduce the risk of heart diseases by approximately 30%
over a 5-year period [12]. Surveys in China have showed
that the awareness, treatment and control of dyslipidemia is poor [1,8,13], and only limited studies on the
influencing factors associated with the awareness, treatment and control of dyslipidemia in China have been
carried out.
The aims of this study were: (1) to estimate the awareness, treatment, and control of dyslipidemia in the adult
population in the Jilin province; and (2) to determine the
influence factors associated with the awareness, treatment and control of dyslipidemia in the adult population
in the Jilin province.

Study population

Materials and methods

Definitions

Ethical statement

Dyslipidemia was defined according to the Chinese
guidelines on the prevention and treatment of dyslipidemia in adults (2007) [6]: TC ≥ 6.22 mmol/L (240 mg/
dL) as high; LDL-C ≥ 4.14 mmol/L (160 mg/dL) as high;
HDL-C < 1.04 mmol/L (40 mg/dL) as low; and TG ≥

The study was approved by the Institutional Review
Board of the School of Public Health, Jilin University,
and all subjects participated in the study after making
signed informed consents.

Data were obtained from the survey of chronic disease
and risk factors among adults in the Jilin province of
China in 2012. The investigation was a cross-sectional
study that aimed to assess chronic disease and associated
risk factors among different populations in different regions of the Jilin province in China. The survey used a
multistage cluster random sampling method to select a
representative sample of permanent residents aged 18 to
79 years in nine different cities in the Jilin province. The
detailed sampling process has been published elsewhere
[14]. A total of 17,729 participants completed the survey
and examination after excluding some participants due
to incomplete blood lipid information. Among the
17,729 respondents, a total of 7,138 subjects had dyslipidemia and were included in the study.
Data collection
Questionnaire interview

The study used a personal health survey questionnaire
established by the School of Public Health, Jilin University.
A direct face-to-face questionnaire interview was carried
out by uniformly trained investigators.
The questionnaire provided the demographic information (such as region, age, gender, level of education, occupation), health behaviors (such as smoking, drinking,
diet, physical activity), history of dyslipidemia in the past
one year, and the current treatment of dyslipidemia.
Anthropometric

After the questionnaire interview, participants underwent
anthropometric checks including height and weight.
Weight was measured early in the morning before respondents had eaten, and each physical measurement
was completed by two people together.
Laboratory assay

Fasting blood samples of each respondent were drawn
by venipuncture to measure serum Total Cholesterol
(TC), High Density Lipoprotein Cholesterol (HDL-C),
Low Density Lipoprotein Cholesterol (LDL-C) and
Triglycerides (TG). The tools used for all blood samples
collection were from the same source. After collection, the
samples were placed in a cold chain system before being
collectively transported to a central laboratory. Blood samples were analyzed using MODULE P800 automated biochemistry analyzer (ROCHE, USA).

He et al. Lipids in Health and Disease 2014, 13:122
http://www.lipidworld.com/content/13/1/122

2.26 mmol/L (200 mg/dL) as high. In this study, high
TC, and/or high LDL-C, and/or low HDL-C and/or high
TG, and/or having a history of dyslipidemia disease in the
past one year, and/or currently receiving treatment with
lipid-lowering medications was regarded as dyslipidemia.
Awareness of dyslipidemia was defined as a self-reported
diagnosis of dyslipidemia by a healthcare professional or
treatment with medications within the population defined
as having dyslipidemia. Treatment of dyslipidemia was
defined as using medications to treat dyslipidemia among
participants with dyslipidemia. Dyslipidemia was considered to be controlled among the population defined as
having dyslipidemia and being treated with medication
if TC < 6.22 mmol/L, LDL-C < 4.14 mmol/L, HDL-C ≥
1.04 mmol/L, and TG < 2.26 mmol/L.
Body mass index (BMI) was calculated as weight (kg)
divided by height (m2). Using BMI 24 kg/m2 as cut off
point, participants were broadly categorized into two
main groups: overweight or obesity being defined as
BMI ≥ 24 kg/m2, and underweight or normal being defined as BMI < 24 kg/m2. Smoking was defined as having
smoked at least one cigarette per day in the past 30 days,
or past smokers even if they had exhibited complete abstinence from cigarette use for at least one month [8,15].
Drinking was defined as drinking any kind of purchased
or homemade alcohol-containing beverages on average
more than once a week. Physical activity was defined as
walking, running, going to the gym or other conscious
exercise not less than once a week. Participants with a
family history of dyslipidemia and those who like to eat
animal-based foods and salted foods were ascertained by
questionnaire.
Statistical analysis

EpiData3.1 was used to establish a database from which
and the data was then exported to SPSS 16.0 software
for further statistical analyses. Chi-square (χ2) test was
used to compare the rates of dyslipidemia awareness,
treatment and control between different characteristics
of the participants. Multiple logistic regression analyses
were performed separately for each group to explore the
associations between participants’ characteristics and
dyslipidemia awareness, treatment and control. All statistical tests were two-tailed and P-values ≤ 0.05 considered statistically significant.

Results
Characteristics of the study sample

Table 1 presents the characteristics of the dyslipidemia
subjects. Out of the 7319 study subjects, 50.1% were
from the urban region, 51.1% were men, 48.9% were
women, 30.4% were aged between 45 and 54, the mean
age was 50.50 ± 12.30 years, 69.0% attained a junior high
school or higher education, 88.0% were married, and
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52.4% were manual workers. In terms of BMI distribution, 67.9% were BMI ≥ 24 kg/m2. Only 4.9% had a family history of dyslipidemia. The rate of smoking was
44.2%, and drinking was 33.7%, with 9.2% admitted eating more of animal-based foods, 40.4% more of salted
foods, and 42.3% of the study subjects reported having
regular exercises.
Awareness, treatment and control of dyslipidemia

Table 2 shows the prevalence of dyslipidemia awareness,
treatment and control. Among participants with dyslipidemia, 852 (11.6%) were aware of the diagnosis of their
condition, and the overall rate of dyslipidemia treatment
was 8.4%. Among the 615 dyslipidemia patients receiving medical treatment for dyslipidemia, 214 (34.8%) were
under control.
Awareness of dyslipidemia

The awareness of dyslipidemia increased with age (P <
0.001), with the last age group 65 ~ 79 having the highest
level of awareness, 130(14.5%). Awareness of dyslipidemia also differed significantly by gender with females
being more aware of their dyslipidemia than males (P =
0.018); education with participants who attained university level of education being more aware of their condition compared to lower levels of education (P = 0.006);
There were significant differences between the occupations in awareness of dyslipidemia (P < 0.001), with retired having the highest level of awareness, 332(15.2%).
BMI with subjects having BMI ≥ 24 kg/m2 being more
aware than those with BMI < 24 kg/m2 (P < 0.001); and
participants with family history of dyslipidemia had
higher levels of awareness of dyslipidemia compared to
those without any history of the condition (P < 0.001).
Smoking, drinking and physical activity were associated
with higher levels of dyslipidemia awareness (all P <
0.01). The awareness of dyslipidemia was not significantly associated with residential area (P = 0.083), marital status (P = 0.058), or whether the participants like
more of animal-based foods (P = 0.055) or salted foods
(P = 0.184).
Treatment of dyslipidemia

The treatment rate increased with age (P < 0.001), with
the last age group 65 ~ 79 having the highest rate of
treatment, 101(11.2%); and differed significantly by gender (P = 0.014) and occupation (P < 0.001) with females
and retired having higher treatment rates compared to
males and manual workers respectively. The level of dyslipidemia treatment was also significantly associated with
BMI and a family history of dyslipidemia (all P < 0.001)
with subjects with BMI ≥ 24 kg/m2 and those with a
family history of dyslipidemia having higher treatment
rates as against those with BMI < 24 kg/m2 or without a
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Table 1 Characteristics of the study sample (n = 7319)
2012, Jilin province, China
Variables

Table 1 Characteristics of the study sample (n = 7319)
2012, Jilin province, China (Continued)

N

%

Urban

3653

50.1

Rural

3666

49.9

Male

3740

51.1

Female

3579

48.9

18~

821

11.2

35~

1388

19.0

45~

2225

30.4

55~

1987

27.1

65 ~ 79

898

12.3

family history of dyslipidemia respectively. Smoking
(P = 0.004), drinking (P < 0.001), liking to eat salted
foods (P = 0.035) and physical activity (P < 0.001) were
all associated with higher levels of dyslipidemia treatment. In this present study, treatment of dyslipidemia
was not found to be significantly associated with residential area (P = 0.863), level of education (P = 0.146),
marital status (P = 0.328), or liking to eat animal-based
foods (P = 0.094) or salted foods (P = 0.035).

Primary school or low

2269

31.0

Control of dyslipidemia

Junior high school

2090

28.6

Senior high school

1956

26.7

University

1004

13.7

Married

6444

88.0

Single/Divorced/Widowed

875

12.0

Regions

Physical activity
No

4222

57.7

Yes

3097

42.3

Gender

Age group (years)

Education

Marital status

Occupation
Manual workers

3832

52.4

Mental workers

1297

17.7

Retired

2190

29.9

No

2346

32.1

Yes

4973

67.9

No

6959

95.1

Yes

360

4.9

No

4087

55.8

Yes

3232

44.2

BMI ≥ 24 kg/m

2

Family history of dyslipidemia

Smoking

Drinking
No

4853

66.3

Yes

2446

33.7

No

6647

90.8

Yes

672

9.2

Like to eat animal-based foods

Like to eat salted foods
No

4363

59.6

Yes

2956

40.4

Among dyslipidemia patients receiving medical treatment for dyslipidemia, participants with BMI < 24 kg/m2
were more likely to have their dyslipidemia controlled
than those with BMI ≥ 24 kg/m2 (P < 0.001). Smoking
was associated with a lower level of dyslipidemia control
than non-smoking (P < 0.001).
Factors associated with awareness, treatment and control
of dyslipidemia

In a multivariate binary logistic regression analysis, awareness, treatment, and control of dyslipidemia were used as
dependent variables; and the parameters which were significantly associated with awareness, treatment, and control of
dyslipidemia in the χ2 test (P < 0.05 in Table 2), were used
as independent variables respectively.
As shown in Table 3, the prevalence of the awareness
of dyslipidemia was significantly associated with increasing age, and there was a significant association between
education and the awareness of dyslipidemia. Retired
participants more likely to aware of their dyslipidemia condition than manual workers (OR = 1.255; 95% CI: 1.046,
1.506). Subjects with BMI ≥ 24 kg/m2 tended to be more
aware of their dyslipidemia condition than those with
BMI < 24 kg/m2 (OR = 1.547; 95% CI: 1.307,1.832). In
addition, having a family history of dyslipidemia increased
the tendency of awareness of dyslipidemia (OR = 3.620;
95% CI: 2.816, 4.653). Alcohol drinkers (OR = 0.780; 95%
CI: 0.658, 0.925) or those who regularly do physical exercises (OR = 0.714; 95% CI: 0.606, 0.842) were unlikely to be
aware of their dyslipidemia condition.
Table 4 illustrates that increasing age was significantly
associated with the treatment of dyslipidemia, with retired (OR = 1.367; 95% CI: 1.114, 1.676) being more
likely to be treated than manual workers. The higher the
level of BMI the more likely that the respondent will
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Table 2 Awareness, treatment and control of dyslipidemia by characteristics, 2012, Jilin province, China
Awarenessa

Variables
N(%)
Total

Treatmenta
P

852(11.6)

Residential areas

N(%)

449(12.3)

Rural

403(11.0)

Gender

P

615(8.4)
0.083

Urban

Controlb
N(%)

0.863
309(8.5)

0.075
97(31.4)

306(8.3)
0.018

117(38.2)
0.014

0.058

Male

403(10.8)

285(7.6)

88(30.9)

Female

449(12.5)

330(9.2)

126(38.2)

Age group (years)
18~

<0.001
24(2.9)

<0.001

0.886

15(1.8)

4(26.7)

35~

130(9.4)

87(6.3)

33(37.9)

45~

283(12.7)

201(9.0)

72(35.8)

55~

285(14.3)

211(10.6)

70(33.2)

65 ~ 79

130(14.5)

101(11.2)

35(34.7)

Education

0.006

0.146

0.075

Primary school or lower

225(9.9)

168(7.4)

63(37.5)

Junior high school

249(11.9)

192(9.2)

71(37.0)

Senior high school

238(12.2)

163(8.3)

59(36.2)

University

140(13.9)

Marital status

92(9.2)
0.058

Married
Single

21(22.8)
0.328

0.993

767(11.9)

549(8.5)

191(34.8)

85(9.7)

66(7.5)

23(34.8)

Occupation

<0.001

Manual workers

351(9.2)

Mental workers
Retired

<0.001

0.529

253(6.6)

92(36.4)

169(13.0)

109(8.4)

33(30.3)

332(15.2)

253(11.6)

89(35.2)

BMI ≥ 24 kg/m

2

<0.001

No

206(8.8)

Yes

646(13.0)

Family history of dyslipidemia

<0.001
144(6.1)

<0.001
69(47.9)

471(9.5)
<0.001

145(30.8)
<0.001

0.948

No

745(10.7)

541(7.8)

188(34.8)

Yes

107(29.7)

74(20.6)

26(35.1)

Smokers

<0.001

No

524(12.8)

Yes

328(10.1)

Drinking

0.004
377(9.2)

<0.001
153(40.6)

238(7.4)
<0.001

61(25.6)
<0.001

0.082

No

616(12.7)

454(9.4)

167(36.8)

Yes

236(9.6)

161(6.5)

47(29.2)

Like to eat animal-based foods

0.055

P

214(34.8)

0.094

0.912

No

789(11.9)

570(8.6)

198(34.7)

Yes

63(9.4)

45(6.7)

16(35.6)
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Table 2 Awareness, treatment and control of dyslipidemia by characteristics, 2012, Jilin province, China (Continued)
Like to eat salted foods

0.184

No

490(11.2)

Yes

362(12.2)

Physical activity

0.035

0.061

342(7.8)

130(38.0)

273(9.2)
<0.001

84(30.8)
<0.001

0.689

No

587(13.9)

423(10.0)

145(34.3)

Yes

265(8.6)

192(6.2)

69(35.9)

a

among all dyslipidemia subjects.
b
among those who received treatment.

receive treatment for dyslipidemia (OR = 1.575; 95% CI:
1.294, 1.918). Subjects with a family history of dyslipidemia were more likely than those without family history
to report drug treatment among participants with dyslipidemia (OR = 3.298; 95% CI: 2.488, 4.371).
Table 3 Multivariate logistic regression analyses on
influence factors for awareness of dyslipidemia, 2012,
Jilin province, China
Awarenessa

Variables
OR

95% CI

P

Age group (years)

As shown in Table 5, among the study subjects with dyslipidemia who were treated with drugs, BMI ≥ 24 kg/m2
was associated with poor control of dyslipidemia (OR =
0.480; 95% CI: 0.326, 0.706). Smokers were less likely to
control their serum lipids at normal levels (OR = 0.501;
95% CI: 0.349, 0.719).
Table 4 Multivariate logistic regression analyses on
influence factors for treatment of dyslipidemia, 2012,
Jilin province, China
Treatmenta

Variables

18-

1.000

35-

3.865

45-

5.481

3.554,8.453

<0.001

18-

1.000

55-

6.491

4.170,10.105

<0.001

35-

3.816

65-79

6.420

3.989,10.332

<0.001

45-

5.338

3.126,9.112

<0.001

55-

6.043

3.519,10.377

<0.001

65-79

6.064

3.425,10.727

<0.001

OR
2.464,6.062

<0.001

Education
Primary school or lower

1.000

Junior high school

1.425

1.165,1.743

0.001

95% CI

P

2.184,6.669

<0.001

Age group (years)

Occupation

Senior high school

1.361

1.095,1.691

0.005

Manual workers

1.000

University

1.835

1.366,2.466

<0.001

Mental workers

1.183

0.923,1.515

0.184

Retired

1.367

1.114,1.676

0.003

1.294,1.918

<0.001

2.488,4.371

<0.001

0.620,0.923

0.006

1.110,1.567

0.002

0.567,0.824

<0.001

Occupation

BMI ≥ 24 kg/m2

Manual workers

1.000

Mental workers

1.083

0.848,1.384

0.521

No

1.000

Retired

1.255

1.046,1.506

0.014

Yes

1.575

BMI ≥ 24 kg/m

2

Family history of dyslipidemia

No

1.000

Yes

1.547

1.307,1.832

<0.001

No

1.000

Yes

3.298

Drinking

Family history of dyslipidemia
No

1.000

Yes

3.620

2.816,4.653

<0.001

No

1.000

Yes

0.756

Like to eat salted foods

Drinking
No

1.000

Yes

0.780

0.658,0.925

0.004

No

1.000

Yes

1.319

Physical activity

Physical activity
No

1.000

Yes

0.714

0.606,0.842

Method: Forward: LR; OR = odds ratio; CI = confidence interval.
a
among all dyslipidemia subjects.

<0.001

No

1.000

Yes

0.683

Method: Forward: LR; OR = odds ratio; CI = confidence interval.
a
among all dyslipidemia subjects.
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Table 5 Multivariate logistic regression analyses on
influence factors for control of dyslipidemia, 2012, Jilin
province, China
Controlb

Variables
OR

95% CI

P

0.326,0.706

<0.001

0.349,0.719

<0.001

BMI ≥ 24 kg/m2
No

1.000

Yes

0.480

Smoking
No

1.000

Yes

0.501

Note: Method: Forward: LR; OR = odds ratio; CI = confidence interval.
b
among those who receiving treatment.

Discussions
With economic growth and associated changes in lifestyle and diet, the level of serum cholesterol in the Chinese
population has greatly increased [4,16]. Dyslipidemia is a
major pathogenic factor of atherosclerosis, and one of
the independent risk factors for cardiovascular disease
such as coronary heart disease and stroke [1,5]. Increasing the awareness and management of patients with
dyslipidemia has a positive impact on cardiovascular
disease prevention [11]. Despite this, numerous studies
have revealed poor awareness and unsatisfactory treatment and control in many European countries [17], and
extremely low rates of dyslipidemia in the Chinese population [3,6,8,13]. It has been reported that the awareness,
treatment, and control rates of dyslipidemia were comparatively low among Chinese adults aged 18 and above,
at 10.93%, 6.84% and 35.3% respectively in 2010 [1]. We
found similar results in this present study with rates of
awareness and treatment among participants being 11.6%
and 8.4% respectively. However, the rates in our study
were significantly less than the 22.2% awareness of diagnosis and 46.1% receiving treatment among adults in Beijing,
China in 2012 [8]. Out of the 615 dyslipidemia individuals
in our study that were receiving treatment, 34.8% were
under control. This is slightly lower than the 37.8% serum
lipids control finding of Cai et al. [8] among those with
dyslipidemia receiving treatment. This indicates that dyslipidemia is an important health risk factors in the Jilin
province. However, only limited studies on the influencing
factors associated with awareness, treatment and control
of dyslipidemia had been carried out in China. Hence our
study aimed to examine the awareness, treatment, and
control of dyslipidemia, and their influence factors in the
Jilin province.
Because dyslipidemia is almost asymptomatic and its
detection requires blood analysis which in most cases requested by a physician, ordinary residents are hardly
aware of and being treated for dyslipidemia disease [17].
The results of our study revealed that the awareness and

treatment of dyslipidemia among our study population
increased concomitantly with age. This is in line with
other studies such as the rate of awareness among residents in Beijing being less than 15% among adults aged
45 and above [18], and the awareness rate also increasing with age among residents in Laiwu city, China [19].
This means that as people advance in age, they become
more concerned about their health, particularly being
concerned about cardiovascular diseases, than younger
individuals who are less likely to attach great importance
to disease consciousness.
Several recent studies showed that education is positively associated with the awareness of dyslipidemia
[10,18,20,21]. The more an individual attains higher
levels of education, the more likely awareness about
health conditions, including dyslipidemia, increases. Regarding the determinants of awareness in our study, an
increasing education level was associated with a higher
level of dyslipidemia awareness.
Our study also showed that compared with manual
workers, retired participants were more likely to be
aware of their dyslipidemia condition and seek treatment. This may be related to retirees, students having
more time to focus on their health, and tend to seek
early management of any adverse health condition.
However, manual workers always appear body fatigue
after a whole day’s work, so they easily ignore the condition body health.
Obesity is an independent risk factor of dyslipidemia
[17,22]. Findings from the ORISCAV-LUX study revealed that obese subjects are more conscious of cardiovascular health risks than slim individuals. This is
helpful in increase their awareness of the underlying silent metabolic pathologies associated with excess body
weight [17]. Our findings are consistent with other studies that overweight or obesity (BMI ≥ 24 kg/m2) is associated with higher levels of dyslipidemia awareness and
treatment [19,20,23]. Individuals with BMI ≥ 24 kg/m2
tend to control their BMI at 24 kg/m2 or less, which
helps in preventing 50-60% risk of hypertriglyceridemia
in this population [24]. However, among individuals receiving treatment, individuals with BMI ≥ 24 kg/m2 are
less likely to have controlled dyslipidemia. This finding
is similar to the results of Long’s study in 2007 [22]. The
plausible explanation is that weight control is a lengthy
process, and it is more difficult to control blood lipids in
overweight or obese people.
People with a family history of dyslipidemia have a
higher risk of developing dyslipidemia [1]. In this study,
we found that family history of dyslipidemia was a strong
predictor of dyslipidemia awareness and treatment. Unsurprisingly, having a family member with dyslipidemia would
increase the consciousness and alertness of the whole family with regards to dyslipidemia, and physicians tend to pay
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more attention to patients with a family history of dyslipidemia, as they tend to have increased risk of cardiovascular
diseases.
Consistent with other findings [19], our study revealed
physical activity is associated with lower levels of awareness and treatment of dyslipidemia. This may be explained by the fact that people who exercise regularly
believe they are less likely to become sick, and therefore
are less likely to be conscious of dyslipidemia.
Lower levels of awareness and treatment were found
among alcohol drinkers and also lower levels of dyslipidemia control among cigarette smokers in the present
study. This may be explained that the dyslipidemia patients who are alcohol drinkers and cigarette smokers
usually receive advice on drinking and smoking cessation
given by physicians, or it may be associated with alcohol
drinkers and smokers’ lower level of concern about their
own health [18,25]. Several studies have found that lifestyle changes are effective in controlling serum blood
lipids [8,19,26]. Thus it is important to emphasize the
need for policies that improve healthy lifestyle.
Study limitations

The findings should be interpreted with an understanding of the following potential limitations. The crosssectional nature of our study design means that causal
associations can only be made with caution. As in many
surveys, our serum lipid levels and the definitions of
dyslipidemia awareness, treatment, and control were
based on measurements taken during a single visit. Potential sources of bias include recall bias of self-reported
information. Treatment and control rates were based on
only pharmacological treatment of dyslipidemia, however, it
is possible to control serum lipid by non-pharmacological
means, such as diet and/or exercise. The Chinese criteria
were adopted to define dyslipidemia; therefore, we could
not directly compare our results with those from other
countries.

Conclusions
In conclusion, our study highlighted the low rates of
awareness, treatment and control of dyslipidemia among
adults aged 18–79 in the Jilin province, China. Continuous efforts are needed to increase the awareness, treatment and control of dyslipidemia taking influence
factors into account. Our results suggest that the relevant departments should regularly carry out health education programs on dyslipidemia. These departments
should also provide guidelines that help promote healthy
lifestyles such as increased physical activity, weight control, smoking cessation and cessation of alcohol drinking.
Establishment of a comprehensive strategy of screening,
treating and controlling of dyslipidemia is needed in the
Jilin Province. These interventions will help to reduce the
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high and increasing burden of cardiovascular disease in
the Jilin province, China.
Abbreviations
CVD: Cardiovascular disease; TC: Total cholesterol; HDL-C: HDL cholesterol;
LDL-C: LDL cholesterol; TG: Triglycerides; BMI: Body mass index.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YQY, YWL, CGK, BL, YCT, QZ, HH and CW designed the study and
participated in acquisition of data; HH, CW and YL researched and evaluated
the literature; HH undertook the statistical analysis and wrote the first draft of
the manuscript. YWL, JSK, XFH and MH revised the manuscript critically for
important intellectual content and languages. All authors have approved the
final manuscript for publication.
Acknowledgements
The authors gratefully acknowledge the financial support from the Scientific
Research Foundation of the Health Bureau of Jilin Province, China (grant
number: 2011Z116). We thank Yan-hua Wu, Yuan Tang, Zhi-hui Yan, Le Lv
and Fan-yu Liu who participated in this study. The authors have no
competing interests.
Author details
1
Department of Epidemiology and Biostatistics, School of Public Health, Jilin
University, Changchun 130021, China. 2Illawarra Health and Medical Research
Institute, University of Wollongong, Wollongong NSW2522, Australia.
Received: 13 May 2014 Accepted: 23 July 2014
Published: 3 August 2014
References
1. Li JH, Wang L, Mi SQ, Zhang M, Jiang Y, Xu Y, Dai M, Wang L: Awareness
rate, treatment rate and control rate of dyslipidemia in Chinese adults,
2010. Chin J Prev Med 2012, 46(8):687–691.
2. Deng B, Luo T, Huang Y, Shen T, Ma J: Prevalence and determinants of
hyperlipidemia in moderate altitude areas of the yunnan-kweichow
plateau in southwestern china. High Alt Med Bio 2012, 13(1):13–21.
3. Li L, Rao K, Kong L, Yao C, Xiang H, Zhai F, Ma G, Yang X: A description on
the Chinese national nutrition and health survey in 2002. Chin J
Epidemiol 2005, 26(7):478–484.
4. Wang S, Xu L, Jonas JB, You QS, Wang YX, Yang H: Prevalence and
associated factors of dyslipidemia in the adult Chinese population.
PLoS One 2011, 6(3):e17326.
5. Luo JY, Ma YT, Yu ZX, Yang YN, Xie X, Ma X, Liu F, Li XM, Chen BD:
Prevalence, awareness, treatment and control of dyslipidemia among
adults in Northwestern China: the cardiovascular risk survey. Lipids Health
Dis 2014, 13(1):4.
6. China Adult Dyslipidemia Prevention Committee: China Adult Dyslipidemia
Prevention Guide. Beijing, China: People’s Health Publishing House; 2007.
7. Li JH, Mi SQ, Li YC, Zhang M, Bi YF, Jiang Y, Wang LM, Ning G, Zhao WH:
The levels and distribution of the serum lipids in Chinese adults, 2010.
Chin J Prev Med 2012, 46(7):607–612.
8. Cai L, Zhang L, Liu A, Li S, Wang P: Prevalence, awareness, treatment, and
control of dyslipidemia among adults in Beijing, China. J Atheroscler
Thromb 2011, 19(2):159–168.
9. Penalva RA, Huoya Mde O, Correla LC, Feitosa GS, Ladeia AM: Lipid profile
and intensity of atherosclerosis disease in acute coronary syndrome.
Arq Bras Cardiol 2008, 90(1):24–30.
10. McDonald M, Hertz RP, Unger AN, Lustik MB: Prevalence, awareness, and
management of hypertension, dyslipidemia, and diabetes among United
States adults aged 65 and older. J Gerontol A Biol Sci Med Sci 2009,
64(2):256–263.
11. Janus ED, Tideman PA, Dunbar JA, Kilkkinen A, Bunker SJ, Philpot B,
Tirimacco R, Mc Namara K, Heistaro S, Laatikainen T: Dyslipidaemia in rural
Australia: prevalence, awareness, and adherence to treatment guidelines
in the greater green triangle risk factor study. Med J Aust 2010,
192(3):127–132.

He et al. Lipids in Health and Disease 2014, 13:122
http://www.lipidworld.com/content/13/1/122

Page 9 of 9

12. Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, Psaty
BM: Dyslipidemia prevalence, treatment, and control in the multi-ethnic
study of atherosclerosis (MESA) gender, ethnicity, and coronary artery
calcium. Circulation 2006, 113(5):647–656.
13. He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, Chen J, Liu D, Mo J,
Whelton PK: Serum total and lipoprotein cholesterol levels and
awareness, treatment, and control of hypercholesterolemia in China.
Circulation 2004, 110(4):405–411.
14. Wang SB, Kou CG, Liu YW, Li B, Tao YC, Liu Y, Zhong L, Fan M, Zhu Y, Liu Z,
Liu Z, Yu YQ: Analysis on prevalence rate and disease spectrum of
chronic disease in adult residents in Jilin province. J Jilin Univ (Med
Edition) 2013, 39(5):1045–1050.
15. Yang GH, Ma JM, Liu N, Zhou LN: Smoking and passive smoking in
Chinese, 2002. Chin J Epidemiol 2005, 26(2):77–83.
16. Zhao WH, Zhang J, You Y, Man QQ, Li H, Wang CR, Zhai Y, Li Y, Jin SG, Yang
XG: Epidemiologic characteristics of dyslipidemia in people aged 18
years and over in China. Chin J Prev Med 2005, 39(5):306–310.
17. Alkerwi A, Pagny S, Lair ML, Delagardelle C, Beissel J: Level of unawareness
and management of diabetes, hypertension, and dyslipidemia among
adults in Luxembourg: findings from ORISCAV-LUX study. PLoS One 2013,
8(3):e57920.
18. Fu YY, Yu JM, Wang JH, Sun YH, Liu HF, Hu DY: Factors associated with
dyslipidemia awareness among residents in Beijing: results from CCEIP.
Chin J Practical Intern Med 2010, 30(01):38–40.
19. Li XJ, Bao YZ, Yang FY: Control rate and effective control rate of
dyslipidemia and their influence factors among residents in Laiwu city.
Chin J Public Health 2012, 28(10):1367–1369.
20. Upadhyay UD, Waddell EN, Young S, Kerker BD, Berger M, Matte T, Angell
SY: Prevalence, awareness, treatment, and control of high LDL
cholesterol in New York City, 2004. Prev Chronic Dis 2010, 7(3):A61.
21. Frontini MG, Srinivasan SR, Elkasabany A, Berenson GS: Awareness of
hypertension and dyslipidemia in a semirural population of young
adults: the Bogalusa heart study. Prev Med 2003, 36(4):398–402.
22. Qu L, Li FY, Lin W: Prevalence and treatment status of dyslipidemia in
middle-aged and old people in kexuecheng community. Modern Prev
Med 2007, 34(11):2082–2084.
23. Fu YY, Yu JM, Wang JS, Sun YH, Liu HJ, Hu DY: Prevalence and awareness
of dyslipidemia among overweight and obese population in Beijing
community. Chin J Cardiol 2010, 38(6):562–566.
24. China ILSI, Office, Working Group On Obesity In China: The introduction on
recommendations of body mass index classification in Chinese adult.
Chin J Prev Med 2001, 35(5):349–350.
25. Agyemang C, van Valkengoed I, Koopmans R, Stronks K: Factors associated
with hypertension awareness, treatment and control among ethnic
groups in Amsterdam, the Netherlands: the SUNSET study. J Hum
Hypertens 2006, 20(11):874–881.
26. Hu AY, Wang JH: The status quo of Chinese prevention and treatment of
dyslipidemia. Chin J Pract Intern Med 2009, 29(1):2–4.
doi:10.1186/1476-511X-13-122
Cite this article as: He et al.: Dyslipidemia awareness, treatment, control
and influence factors among adults in the Jilin province in China: a
cross-sectional study. Lipids in Health and Disease 2014 13:122.

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

